K. Margolin

Immunology · 2001–2023

A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom K. Margolin trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Leonard (in Immunology)

Papers from K. Margolin's perspective

Ordered by how strongly the researchers K. Margolin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  2. Control of T‐cell activation by CD4+ CD25+ suppressor T cells (Immunological Reviews)
  3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
  4. Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
  5. Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood (Journal of Experimental Medicine)
  6. Safety and clinical activity of combined PD-1 (nivolumab) and CTLA-4 (ipilimumab) blockade in advanced melanoma patients (New England Journal of Medicine)
  7. Final version of 2009 AJCC melanoma staging and classification. (Journal of Clinical Oncology)
  8. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine)
  9. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma (New England Journal of Medicine)
  10. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo (Nature Immunology)

Their papers